Neopterin levels and dexamethasone suppression test in obsessive-compulsive disorder

dc.contributor.authorKuloglu, Murat
dc.contributor.authorAtmaca, Murad
dc.contributor.authorOnal, Suleyman
dc.contributor.authorGecici, Omer
dc.contributor.authorBulut, Vedat
dc.contributor.authorTezcan, Ertan
dc.date.accessioned2026-08-12T17:44:57Z
dc.date.issued2007
dc.departmentFırat Üniversitesi
dc.description.abstractNeopterin, a biopterin precursor that is released by macrophages, is an important immunological marker in psychiatric disorders. It has been reported that glucocorticoids may cause suppression of cell-mediated immunity and consequently result in decreased neopterin levels. In the present study, we evaluated whether dexamethasone suppression test (DST) and neopterin findings were associated with pure obsessive-compulsive disorder (OCD) patients (OCD-D group) and the concomitant OCD and depression (OCD+D group). The sample comprised 44 patients with OCD (27 with OCD-D and 17 with OCD+D) and 30 control subjects. There was significantly higher DST nonsuppression in the OCD+D group than in the OCD-D group. With regard to mean neopterin levels, there was no significant difference between the OCD-D group and the control group, but there was a statistically significant difference between the OCD+D group and the control group. The OCD+D group had significantly lower neopterin levels than the 20 OCD-D group. We suggest that this distinction may reflect the fact that glucocorticoids can lead to suppression of cell-mediated immunity and consequently can result in decreased neopterin levels. In conclusion, our results suggest that not the OCD-D group had normal neopterin levels and DST results, and also that OCD may be a heterogeneous subtype characterized by some biological indicators or anxiety and affective disorders. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
dc.identifier.doi10.1016/j.psychres.2002.04.001
dc.identifier.endpage270
dc.identifier.issn0165-1781
dc.identifier.issue3
dc.identifier.orcid0000-0002-0508-2127
dc.identifier.pmid17467061
dc.identifier.scopus2-s2.0-34249700836
dc.identifier.scopusqualityQ1
dc.identifier.startpage265
dc.identifier.urihttps://doi.org/10.1016/j.psychres.2002.04.001
dc.identifier.urihttps://hdl.handle.net/11508/60465
dc.identifier.volume151
dc.identifier.wosWOS:000247650800011
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Ireland Ltd
dc.relation.ispartofPsychiatry Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectOCD
dc.subjectneopterin
dc.subjectDST
dc.subjectdepression
dc.titleNeopterin levels and dexamethasone suppression test in obsessive-compulsive disorder
dc.typeArticle

Dosyalar